Free Trial
NASDAQ:CANB

Can B 5/22/2023 Earnings Report

Can B EPS Results

Actual EPS
-$0.36
Consensus EPS
$0.06
Beat/Miss
Missed by -$0.42
One Year Ago EPS
N/A

Can B Revenue Results

Actual Revenue
$0.94 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Can B Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Can B Earnings Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
This summer, President Trump could unlock what one former White House advisor calls the largest wealth transfer in U.S. history. Jim Rickards says a $150 trillion national asset—spread across all 50 states—may soon be released after decades of being locked away. And while citizens won’t receive direct payouts, certain investors could benefit significantly.
See More Can B Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Can B? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Can B and other key companies, straight to your email.

About Can B

Can B (NASDAQ:CANB) engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

View Can B Profile

More Earnings Resources from MarketBeat